Chongqing Xishan Science and Technology Co (SHSE:688576) Debt-to-EBITDA : 0.02 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Chongqing Xishan Science and Technology Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Chongqing Xishan Science and Technology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥1.8 Mil. Chongqing Xishan Science and Technology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥0.1 Mil. Chongqing Xishan Science and Technology Co's annualized EBITDA for the quarter that ended in Mar. 2024 was ¥120.8 Mil. Chongqing Xishan Science and Technology Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 0.02.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Chongqing Xishan Science and Technology Co's Debt-to-EBITDA or its related term are showing as below:

SHSE:688576' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.09 Med: 0.05 Max: 0.51
Current: 0.01

During the past 7 years, the highest Debt-to-EBITDA Ratio of Chongqing Xishan Science and Technology Co was 0.51. The lowest was -1.09. And the median was 0.05.

SHSE:688576's Debt-to-EBITDA is ranked better than
99.76% of 425 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs SHSE:688576: 0.01

Chongqing Xishan Science and Technology Co Debt-to-EBITDA Historical Data

The historical data trend for Chongqing Xishan Science and Technology Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Xishan Science and Technology Co Debt-to-EBITDA Chart

Chongqing Xishan Science and Technology Co Annual Data

Trend

Dec13

Dec14

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

Get a 7-Day Free Trial

-0.73

0.51

0.14

0.07

0.02

Chongqing Xishan Science and Technology Co Quarterly Data
	Dec13	Dec14	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-EBITDA	Get a 7-Day Free Trial										0.05	0.05	0.04	0.01	0.02

Competitive Comparison of Chongqing Xishan Science and Technology Co's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Chongqing Xishan Science and Technology Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chongqing Xishan Science and Technology Co's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chongqing Xishan Science and Technology Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Chongqing Xishan Science and Technology Co's Debt-to-EBITDA falls into.

Chongqing Xishan Science and Technology Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Chongqing Xishan Science and Technology Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(3.006	+	0.088)	/	137.78
	=	0.02

Chongqing Xishan Science and Technology Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1.846	+	0.066)	/	120.792
	=	0.02

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.

Chongqing Xishan Science and Technology Co (SHSE:688576) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Chongqing Xishan Science and Technology Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Chongqing Xishan Science and Technology Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Chongqing Xishan Science and Technology Co (SHSE:688576) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chongqing Xishan Science and Technology Co Ltd (SHSE:688576) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 9, Middle Section of Huangshan Avenue, Jupiter Science and Technology Development Center, High-tech Park, North New District, Chongqing, CHN, 401121

Website

https://www.xishantech.com.cn

Chongqing Xishan Science and Technology Co Ltd focuses on surgical instruments, especially in the field of minimally invasive surgical instruments. It is mainly engaged in the research, development, production and sales of minimally invasive surgical instruments. Speculum, energy surgery equipment and other products, currently the products are mainly used in neurosurgery, ENT, orthopedics, breast surgery and other clinical departments. The company's main products are surgical power units, consumables and accessories, which are mainly used for cutting, grinding, planing, sawing, milling and trimming of bone tissue and soft tissue in surgical operations, especially minimally invasive surgical operations.

Chongqing Xishan Science and Technology Co (SHSE:688576) Headlines

No Headlines